Response to platinum-based therapies in second-line after immunotherapy in advanced or metastatic non-small-cell lung cancer PD-L1 ≥50%

  1. Olivares-Hernández, A.
  2. Posado-Domínguez, L.
  3. Redondo-González, J.C.
  4. Corvo-Félix, L.
  5. Hernández, L.B.
  6. Fonseca-Sánchez, E.
  7. del Barco-Morillo, E.
Journal:
Translational Lung Cancer Research

ISSN: 2226-4477 2218-6751

Year of publication: 2024

Volume: 13

Issue: 10

Pages: 2649-2659

Type: Article

DOI: 10.21037/TLCR-24-513 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals